Published in Neuroimage on August 31, 2007
Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain (2012) 1.22
Manganese enhanced MRI (MEMRI): neurophysiological applications. Rev Neurosci (2011) 1.03
Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One (2010) 1.01
Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI. Neuroimage (2011) 0.94
Axonal transport declines with age in two distinct phases separated by a period of relative stability. Neurobiol Aging (2014) 0.87
Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI. Neuroimage (2012) 0.85
Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function. J Neurosci (2010) 0.84
Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI. Neuroimage (2012) 0.83
Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation. Front Aging Neurosci (2014) 0.82
In vivo axonal transport deficits in a mouse model of fronto-temporal dementia. Neuroimage Clin (2014) 0.81
Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer's disease. Neurobiol Aging (2010) 0.81
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J Nucl Med (2013) 0.80
Axonal transport rate decreased at the onset of optic neuritis in EAE mice. Neuroimage (2014) 0.77
Manganese-Enhanced MRI: Biological Applications in Neuroscience. Front Neurol (2015) 0.76
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75
Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke (2006) 4.85
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol (2011) 4.76
Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol (2010) 3.08
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain (2007) 2.96
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab (2006) 2.16
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med (2005) 2.05
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med (2013) 1.93
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement (2013) 1.87
Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med (2011) 1.67
MR neurography and muscle MR imaging for image diagnosis of disorders affecting the peripheral nerves and musculature. Neurol Clin (2004) 1.61
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma. J Nucl Med (2014) 1.52
Sexually responsive vascular tissue of the vulva. BJU Int (2006) 1.51
Systemic theophylline augments the blood oxygen level-dependent response to forepaw stimulation in rats. AJNR Am J Neuroradiol (2002) 1.50
Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. J Vasc Interv Radiol (2013) 1.48
Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis (2006) 1.48
18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med (2004) 1.46
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol (2009) 1.44
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology (2003) 1.42
Rapid scanning protocol for brain (18)F-FDG PET: a validation study. J Nucl Med (2005) 1.41
In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Ann Neurol (2006) 1.41
Is Chiari I malformation associated with fibromyalgia? Neurosurgery (2011) 1.41
Psychophysical and cerebral responses to heat stimulation in patients with central pain, painless central sensory loss, and in healthy persons. Pain (2011) 1.40
Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms. Neuroimage (2010) 1.39
A unique representation of heat allodynia in the human brain. Neuron (2002) 1.37
Orbital neoplasms in adults: clinical, radiologic, and pathologic review. Radiographics (2013) 1.35
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med (2011) 1.28
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood (2003) 1.25
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.24
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J Nucl Med (2007) 1.23
Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humans. Psychosom Med (2002) 1.22
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat Med (2004) 1.18
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation. Head Neck (2005) 1.15
Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med (2005) 1.14
Statistical mapping of functional olfactory connections of the rat brain in vivo. Neuroimage (2004) 1.12
Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. J Magn Reson Imaging (2011) 1.12
Differential diagnosis of thyroid nodules with US elastography using carotid artery pulsation. Radiology (2008) 1.09
Ultrasound thyroid elastography using carotid artery pulsation: preliminary study. J Ultrasound Med (2007) 1.08
F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis. Clin Nucl Med (2010) 1.08
Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function. Invest Radiol (2016) 1.07
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med (2004) 1.07
Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia (2008) 1.06
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med (2011) 1.06
Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics (2014) 1.05
Mentoring the mentors: Aligning mentor and mentee expectations. Acad Radiol (2006) 1.04
Magnetic resonance imaging anatomy of the female genitalia in premenopausal and postmenopausal women. J Urol (2003) 1.03
Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke (2003) 1.02
Low-frequency signal changes reflect differences in functional connectivity between good readers and dyslexics during continuous phoneme mapping. Magn Reson Imaging (2006) 1.02
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances. AJR Am J Roentgenol (2007) 1.01
Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis (2008) 1.00
FMRI investigation of cross-cultural music comprehension. Neuroimage (2003) 1.00
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology (2009) 0.99
Brain imaging reveals neuronal circuitry underlying the crow's perception of human faces. Proc Natl Acad Sci U S A (2012) 0.99
Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans. J Neurotrauma (2014) 0.97
Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization. Mol Imaging Biol (2006) 0.95
Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. Eur J Nucl Med Mol Imaging (2009) 0.94
Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis. Radiology (2014) 0.93
Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? Am J Med Genet A (2008) 0.93
Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging (2006) 0.92
Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg (2003) 0.92
Female genitalia: dynamic MR imaging with use of MS-325 initial experiences evaluating female sexual response. Radiology (2002) 0.92
Motor cortex activation is preserved in patients with chronic hemiplegic stroke. Ann Neurol (2002) 0.92
Physiology of women's sexual function: basic knowledge and new findings. J Sex Med (2010) 0.91
Insights into the pathophysiology of neuropathic pain through functional brain imaging. Exp Neurol (2003) 0.90
Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Ann Neurol (2003) 0.90
Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. AJNR Am J Neuroradiol (2002) 0.90
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. J Nucl Med (2013) 0.89
Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch Gen Psychiatry (2007) 0.89
Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2008) 0.88
Accuracy of preliminary interpretation of neurologic CT examinations by on-call radiology residents and assessment of patient outcomes at a level I trauma center. J Am Coll Radiol (2009) 0.88
Paramagnetic effect of supplemental oxygen on CSF hyperintensity on fluid-attenuated inversion recovery MR images. AJNR Am J Neuroradiol (2004) 0.87
Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow. Eur J Nucl Med Mol Imaging (2004) 0.86
The brachial plexus: normal anatomy, pathology, and MR imaging. Neuroimaging Clin N Am (2004) 0.86
Interrater agreement in the evaluation of discrepant imaging findings with the Radpeer system. AJR Am J Roentgenol (2012) 0.85
Magnetosonoporation: instant magnetic labeling of stem cells. Magn Reson Med (2010) 0.85
Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia. J Neurol (2002) 0.85
Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla. Head Neck (2012) 0.85
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging. Alzheimers Dement (2013) 0.85
Optimization of magnetosonoporation for stem cell labeling. NMR Biomed (2010) 0.85
Quantitative analysis of neural stem cell migration and tracer clearance in the rat brain by MRI. Mol Imaging Biol (2011) 0.84
Differential SPECT activation patterns associated with PASAT performance may indicate frontocerebellar functional dissociation in chronic mild traumatic brain injury. J Nucl Med (2009) 0.84
Contrast-enhanced MRI of carotid atherosclerosis: dependence on contrast agent. J Magn Reson Imaging (2009) 0.84
MR neurography: diagnostic utility in the surgical treatment of peripheral nerve disorders. Neuroimaging Clin N Am (2004) 0.84
An automated ROI setting method using NEUROSTAT on cerebral blood flow SPECT images. Ann Nucl Med (2009) 0.83
A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings. Clin Nucl Med (2012) 0.83
Distinct neural circuits underlie assessment of a diversity of natural dangers by American crows. Proc Biol Sci (2013) 0.82
FDG-PET and molecular brain imaging in the movement disorders clinic. Neurology (2012) 0.82
Disk position and the bilaminar zone of the temporomandibular joint in asymptomatic young individuals by magnetic resonance imaging. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 0.82